View Filing Data

Document and Entity Information - shares	9 Months Ended
Sep. 30, 2014	Nov. 12, 2014
Document And Entity Information
Entity Registrant Name	Nxt-ID, Inc.
Entity Central Index Key	0001566826
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Type	10-Q
Document Period End Date	Sep. 30, 2014
Document Fiscal Year Focus	2014
Document Fiscal Period Focus	Q3
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		24,691,862

Condensed Consolidated Balance Sheets - USD ($)	Sep. 30, 2014	Dec. 31, 2013
Current Assets
Cash	$ 4,817,935	$ 303,626
Restricted cash	5,963
Inventory	32,619	6,533
Prepaid expenses	173,594	3,313
Total Current Assets	5,030,111	313,472
Property and equipment, net of accumulated depreciation of $3,975 and $684, respectively	36,898	7,734
Total Assets	5,067,009	321,206
Current Liabilities
Accounts payable	296,971	244,094
Accrued expenses	20,223	135,017
Customer deposits	117,088
Convertible notes payable, net of discount of $0 and $26,755, respectively		123,245
Derivative liability - warrants		1,531,303
Conversion feature liability		118,940
Total Current Liabilities	434,282	2,152,599
Commitment and Contingencies
Stockholders' Equity (Deficiency)
Preferred stock, $0.0001 par value: 10,000,000 shares authorized; none issued and outstanding
Common stock, $0.0001 par value: 100,000,000 shares authorized; 24,670,995 and 21,937,822 issued and outstanding, respectively	2,467	2,194
Additional paid-in capital (deficit)	11,339,769	(80,177)
Accumulated deficit	(6,709,509)	(1,753,410)
Total Stockholders' Equity (Deficiency)	4,632,727	(1,831,393)
Total Liabilities and Stockholders' Equity (Deficiency)	$ 5,067,009	$ 321,206

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)	Sep. 30, 2014	Dec. 31, 2013
Balance Sheets [Abstract]
Accumulated Depreciation	$ 3,975	$ 684
Net of discount of convertible notes payable	$ 0	$ 26,755
Preferred Stock, Par Value	$ 0.0001	$ 0.0001
Preferred Stock, Authorized	10,000,000	10,000,000
Preferred Stock, Issued
Preferred Stock, Outstanding
Common Stock, Par Value	$ 0.0001	$ 0.0001
Common Stock, Authorized	100,000,000	100,000,000
Common Stock, Issued	24,670,995	21,937,822
Common Stock, Outstanding	24,670,995	21,937,822

Condensed Consolidated Statements Of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Statements of Operations [Abstract]
Revenues
Cost of goods sold
Gross Profit
Operating Expenses
General and administrative	710,914	246,143	1,468,991	572,147
Selling and marketing	372,371	4,334	749,974	9,823
Research and development	463,054	170,354	887,180	432,361
Total Operating Expenses	1,546,339	420,831	3,106,145	1,014,331
Operating Loss	(1,546,339)	(420,831)	(3,106,145)	(1,014,331)
Other Expense
Interest and other expenses, net		(13,967)	(30,744)	(23,858)
Inducement expense	(1,161,410)		(2,212,538)
Unrealized gain (loss) on change in fair value of derivative liabilities		(39,202)	393,328	(37,560)
Total Other Expense	(1,161,410)	(53,169)	(1,849,954)	(61,418)
Net Loss	$ (2,707,749)	$ (474,000)	$ (4,956,099)	$ (1,075,749)
Net Loss Per Share - Basic and Diluted	$ (0.12)	$ (0.02)	$ (0.22)	$ (0.05)
Weighted Average Number of Common Shares Outstanding - Basic and Diluted	22,640,024	21,568,082	22,223,245	21,261,036

Condensed Consolidated Statements Of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Cash Flows from Operating Activities
Net Loss	$ (4,956,099)	$ (1,075,749)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	3,291	297
Stock based compensation	554,225	255,400
Amortization of debt discount	26,755	11,109
Unrealized (gain) loss on change in fair value of derivative liabilities	(393,328)	37,560
Inducement fee	2,212,538
Changes in operating assets and liabilities:
Inventory	(26,086)	(4,073)
Prepaids	(170,281)
Accounts payable	50,935	200,174
Accrued expenses	(93,309)	45,726
Customer deposits	117,088
Total Adjustments	2,206,866	546,193
Net Cash Used in Operating Activities	(2,674,271)	(529,556)
Cash Flows from Investing Activities
Restricted cash	(5,963)
Purchase of equipment	(30,513)	(1,395)
Net Cash Used in Investing Activities	(36,476)	(1,395)
Cash Flows from Financing Activities
Proceeds received in connection with issuance of common stock and warrants, net	5,754,036
Proceeds received in connection with issuance of common stock, net		246,435
Proceeds received in connection with exercise of warrants	1,470,000	100,000
Proceeds received in connection with issuance of warrants	1,020
Proceeds from convertible notes payable		75,000
Proceeds from advances made by officer		64,000
Repayments of advances made by officer		(64,000)
Net Cash Provided by Financing Activities	7,225,056	421,435
Net Increase/(Decrease) in Cash	4,514,309	(109,516)
Cash - Beginning of Period	303,626	135,820
Cash - End of Period	4,817,935	26,304
Cash paid during the periods for:
Interest
Taxes
Non-cash financing activities:
Recognition of liability in connection with warrant issuance	3,431,541
Reclassification of warrant liability to additional paid-in capital in connection with warrant modification	4,589,734
Issuance of common stock in connection with conversion of note payable and accrued interest	171,485	44,966
Reclassification of conversion feature liability in connection with note conversion	98,722
Retirement of common stock by officers	68
Accrual of common shares to be issued for services

Summary of Significant Accounting Policies

9 Months Ended

Sep. 30, 2014

Summary of Significant Accounting Policies [Abstract]

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Note 3 - Summary Of Significant Accounting Policies

Use of Estimates in the Financial Statements

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Principles of Consolidation

The consolidated financial statements include the accounts of Nxt-ID and its wholly-owned subsidiary, 3D-ID. Intercompany balances and transactions have been eliminated upon consolidation.

Restricted Cash

Restricted cash is comprised of amounts held by credit card processors until the Company establishes a history of activity and the processor is able to estimate potential charge back risk. The balances are rolling and held by the processor for a period of less than a year and therefore reported as a current asset on the accompanying condensed consolidated balance sheets.

Inventory

Inventory consists principally of raw materials and is valued at the lower of cost or market with cost determined using the first-in, first-out method and with market defined as the lower of replacement cost or realizable value. As of September 30, 2014 inventory is comprised of $32,619 in raw materials on hand. In addition, as an early stage entity, the Company is required to prepay for raw materials with certain vendors until credit terms can be established. As of September 30, 2014, $165,153 of prepayments made for inventory is included in prepaid expenses on the condensed consolidated balance sheet.

Revenue Recognition

The Company’s 3D facial recognition and identification products are currently available for sale and the Company has begun accepting pre-orders on its Mobile Bio Wocket. The Company recognizes revenue in connection with the sale of these products when persuasive evidence of an arrangement exists, the service has been rendered or product delivery has occurred, the price is fixed or readily determinable and collectability of the sale is reasonably assured. As of September 30, 2014, the Company has received $117,088 in customer deposits in connection with pre-orders of its Mobile Bio Wocket.

Convertible Instruments

The Company applies the accounting standards for derivatives and hedging and for distinguishing liabilities from equity when accounting for hybrid contracts that feature conversion options. The accounting standards require companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments according to certain criteria. The criteria include circumstances in which (i) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (ii) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (iii) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument.

The derivative is subsequently marked to market at each reporting date based on current fair value, with the changes in fair value reported in the results of operations.

Conversion options that contain variable settlement features, such as provisions to adjust the conversion price upon subsequent issuances of equity or equity linked securities at exercise prices more favorable than that featured in the hybrid contract, generally result in their bifurcation from the host instrument.

The Company accounts for convertible debt instruments when the Company has determined that the embedded conversion options should not be bifurcated from their host instruments in accordance with ASC 470-20 “Debt with

Conversion and Other Options.” The Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt. See Note 4 below.

Debt Discount and amortization of debt discount

Debt discount represents the fair value of embedded conversion options of various convertible debt instruments and attached convertible equity instruments issued in connection with debt instruments. The debt discount is amortized over the earlier of (i) the term of the debt or (ii) conversion of the debt. The amortization of debt discount is included as a component of interest and other expenses, net in the accompanying statements of operations.

Income Taxes

The Company uses the asset and liability method of accounting for income taxes in accordance with ASC Topic 740, "Income Taxes." Under this method, income tax expense is recognized for the amount of: (i) taxes payable or refundable for the current year and (ii) deferred tax consequences of temporary differences resulting from matters that have been recognized in an entity's financial statements or tax returns. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the year in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the results of operations in the period that includes the enactment date. A valuation allowance is provided to reduce the deferred tax assets reported if, based on the weight of the available positive and negative evidence, it is more likely than not that some portion or all of the deferred tax assets will not be realized.

ASC Topic 740-10-30 clarifies the accounting for uncertainty in income taxes recognized in an enterprise's financial statements and prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. ASC Topic 740-10-40 provides guidance on de-recognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition. The Company will classify as income tax expense any interest and penalties. The Company has no material uncertain tax positions for any of the reporting periods presented. Generally, the tax authorities may examine the partnership/corporate tax returns for three years from the date of filing. The Company has filed all of its tax returns for the year ended December 31, 2013. As a result, the Company’s net operating loss carryovers will now be available to offset any future taxable income.

Stock-Based Compensation

The Company accounts for equity instruments issued to non-employees at their fair value on the measurement date. The measurement of stock-based compensation is subject to periodic adjustment as the underlying equity instrument vests or becomes non-forfeitable. Non-employee stock-based compensation charges are amortized over the vesting period or as earned.

Net Loss per Share

Basic loss per share was computed using the weighted average number of common shares outstanding. Diluted loss per share includes the effect of diluted common stock equivalents. Potentially dilutive securities realizable from the exercise of 3,629,776 warrants as of September 30, 2014 were excluded from the computation of diluted net loss per share because the effect of their inclusion would have been anti-dilutive. As of September 30, 2013, potentially dilutive securities realizable from the conversion of the Company’s then outstanding note payable into 120,000 shares of common stock and the exercise of warrants for the purchase of 204,600 common shares were excluded from the computation of diluted net loss per share because the effect of their inclusion would have been anti-dilutive.

Research and Development

Research and development costs consist of expenditures incurred during the course of planned research and investigation aimed at the discovery of new knowledge that would be useful in developing new products or processes. The Company expenses all research and development costs as incurred.

Stockholders' Equity

9 Months Ended

Sep. 30, 2014

Stockholders' Equity [Abstract]

STOCKHOLDERS' EQUITY

Note 5 - Stockholders' Equity

On January 13, 2014, the Company closed a “best efforts” private offering of $1,000,000 (the “Offering”) with a group of accredited investors (the “Purchasers”) and the Company exercised the oversubscription amount allowed in the Offering of $350,000, for total gross proceeds to the Company of $1,350,000 before deducting placement agent fees and other expenses. Pursuant to a securities purchase agreement with the Purchasers (the “Purchase Agreement”), the Company issued to the Purchasers (i) 415,387 shares of the Company’s common stock, par value $0.0001 and (ii) warrants (the “Warrants”) to purchase 1,350,000 shares (the “Warrant Shares”) of the Company’s common stock at an exercise price of $3.25 per share. In connection with the Offering, 138,463 units were sold at the end of December 2013 and 276,924 units were sold in January 2014, all at $3.25 per unit. As a result, the Company received aggregate gross proceeds of $450,000 in December 2013 from the issuance of 138,463 shares of common stock and 450,000 Warrants, and the Company received $900,000 in January 2014 from the issuance of 276,924 shares of common stock and 900,000 Warrants. Costs incurred associated with the Offering in December 2013 and January 2014 were $56,820 and $100,006, respectively. In January 2014, the placement agent received 41,539 Warrants to purchase 41,539 shares of the Company’s common stock as fees.

Pursuant to the Purchase Agreement, the Company’s founders who are members of management (the “Founders”) agreed to cancel a corresponding number of shares to those shares issued in the Offering and place in escrow a corresponding number of shares to be cancelled for each Warrant Share issued. As a result, the Founders retired 138,463 and 276,924 shares of common stock in December 2013 and January 2014, respectively.

The Warrants are exercisable for a period of five (5) years from the original issue date. The initial exercise price with respect to the Warrants was $3.25 per share. On the date of issuance, the Warrants were recognized as derivative liabilities as they did not have fixed settlement provisions because their exercise prices could be lowered if the Company was to issue securities at a lower price in the future. As a result, the Company recorded $3,431,541 as derivative liability warrants on the condensed consolidated balance sheet on January 13, 2014.

On February 21, 2014, the Company amended the terms of the 1,391,539 Warrants issued in the Offering as compensation to the placement agent to eliminate the anti-dilution provision and to lower the exercise price of the Warrants from $3.25 to $3.00. As a result of the Warrant modifications, the Company re-measured the Warrant liability on the modification date and recorded an unrealized gain on derivative liabilities of $448,072 and reclassified the aggregate re-measured value of the Warrants of $4,514,772 to additional paid-in capital. See Note 6 below.

On various dates, during the nine months ended September 30, 2014, the Company received gross proceeds of $1,500,000 in connection with the exercise of 500,000 warrants into 500,000 shares of common stock at an exercise price of $3.00 per share, net of fees paid upon the exercise of the warrants issued in the Offering per the terms of the underwriter agreement of $30,000. Upon exercise, pursuant to the Purchase Agreement, the Company’s Founders cancelled a corresponding number of shares for each Warrant Share issued. As a result, the Founders retired 400,000 shares of common stock.

From June 12, 2014 to June 17, 2014, the Company conducted a private offering with a group of accredited investors (the “June Purchasers”) who had previously participated in the Offering that occurred between December 30, 2013 and January 13, 2014 (as discussed in this Note 5). Pursuant to a securities purchase agreement with the Purchasers, the Company issued to the June Purchasers warrants (the “June Warrants”) to purchase an aggregate of 400,000 shares (the “June Shares”) of the Company’s common stock at an exercise price of $3.00 per share. The June Warrants are exercisable for a period of five (5) years from the original issue date. The exercise price for the June Warrants is subject to adjustment upon certain events, such as stock splits, combinations, dividends, distributions, reclassifications, mergers or other corporate change and dilutive issuances.

In connection with the issuance of the June Warrants, the Company entered into a registration rights agreement with the June Purchasers pursuant to which the Company agreed to register the Shares and the shares of the common stock underlying the June Warrants (the “June Registrable Securities”) on a Form S-1 registration statement (the “June Registration Statement”) to be filed with the SEC ninety (90) days following the completion of an underwritten public offering (the “Filing Date”) and to cause the June Registration Statement to be declared effective under the Securities Act within ninety (90) days following the Filing Date (the “Required Effective Date”).

If the Registration Statement is not filed by the Filing Date or declared effective by the Required Effective Date of December 15, 2014, the Company is required to pay partial liquidated damages to each June Purchaser in the amount equal to two percent (2%) for the purchase price paid for the June Warrants then owned by such June Purchaser for each 30-day period for which the Company is non-compliant.

On August 21, 2014, pursuant to a securities purchase agreement with two (2) Purchasers (the “August Purchasers”) who had previously participated in the Offering that occurred between December 30, 2013 and January 13, 2014 (as discussed in this Note 5), the Company issued to the August Purchasers warrants (the “August Warrants”) to purchase an aggregate of 100,000 shares (the “August Shares”) of the Company’s common stock at an exercise price of $3.00 per share. The August Warrants are exercisable for a period of five (5) years from the original issue date. The exercise price for the August Warrants is subject to adjustment upon certain events, such as stock splits, combinations, dividends, distributions, reclassifications, mergers, or other corporate changes and dilutive issuances.

In connection with the issuance of the August Warrants, the Company entered into a registration rights agreement with the August Purchasers pursuant to which the Company agreed to register the August Shares and the shares of the common stock underlying the August Warrants (the “August Registrable Securities”) on a Form S-1 registration statement (the August Registration Statement”) to be filed with the SEC ninety (90) days following the Filing Date and to cause the August Registration Statement to be declared effective under the Securities Act by the Required Effective Date.

If the August Registration Statement is not filed by the Filing Date or declared effective by the Required Effective Date, the Company is required to pay partial liquidated damages to each August Purchaser in the amount equal to two percent 2% for the purchase price paid for the August Warrants then owned by such August Purchaser for each 30-day period for which the Company is non-compliant.

The Company determined that the effect of the issuance of the 500,000 warrants was to induce the Purchasers to exercise warrants previously issued to them in the Offering. As a result, the Company recorded an inducement expense of $1,262,038 and $210,940 for the nine and three months ended September 30, 2014, respectively.

On September 15, 2014, the Company closed on an underwritten public offering of its common stock and warrants. The Company offered 2,127,273 shares of common stock and warrants to purchase 2,127,273 shares of common stock, at a combined price to the public of $2.75 per share and related warrant. The warrants are exercisable for a period of five (5) years beginning on September 15, 2014 at an exercisable price of $3.288 per share. The Company received net proceeds of $4,954,042 from the public offering, after deducting the underwriting discount and other offering related expenses.

In connection with the underwritten public offering of the Company’s common stock and warrants on September 15, 2014, the Company was required to obtain a waiver and consent from the investors in the January 13, 2014 private offering in order to conduct the public offering at a price of $2.75 per share and warrant. As a result, on September 10, 2014, the Company issued the majority investors in the January 13, 2014 private offering, 261,131 unregistered shares of common stock and reduced the exercise price on the outstanding Warrants, June Warrants, and August Warrants from $3.00 to $2.00 per share of common stock for all of the investors. During the three months ended September 30, 2014, the Company recorded additional inducement expense of $718,110 and $232,360 related to the issuance of unregistered shares of common stock to the majority investors and the modification of the warrant exercise price, respectively.

The following table summarizes the Company's warrants outstanding at September 30, 2014:

Warrants outstanding and exercisable						Weighted
				Weighted		Average
				Average		Remaining
	Number of			Exercise		Life		Intrinsic
	Warrants			Price		In Years		Value

Outstanding at December 31, 2013		454,600		$	3.23		4.97	$	351,300
Issued		3,675,176			2.79		4.76
Exercised		(500,000	)		3.00		-
Cancelled		-			-		-
Outstanding at September 30, 2014		3,629,776		$	2.80		4.76	$	786,438
Exercisable at September 30, 2014		3,629,776		$	2.80		4.76	$	786,438

On January 4, 2013, a majority of the Company’s stockholders approved by written consent the Company’s 2013 Long-Term Stock Incentive Plan (“LTIP”). The maximum aggregate number of shares of common stock that may be issued under the LTIP, including stock awards and stock appreciation rights, is limited to 10% of the shares of common stock outstanding on the first business or trading day of any fiscal year, which is 2,193,782 at January 1, 2014. During the nine and three months ended September 30, 2014, the Company issued 10,943 and 5,859 restricted shares, respectively, under the plan to three non-executive directors with an aggregate fair value of $35,000 and $15,000, respectively. For the nine months ended September 30, 2014, the Company issued 65,830 shares of common stock with an aggregate fair value of $244,000 to consultants for services rendered to the Company. In addition, the Company issued 112,500 shares of common stock with an aggregate fair value of $275,225 to certain of its employees during the nine months ended September 30, 2014.

- Definition

The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(d),(e))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21484-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB TOPIC 4.E)
-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21488-112644

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29-31)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 4
-Subparagraph (SAB TOPIC 4.C)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187143-122770

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Preferred Stock
-URI http://asc.fasb.org/extlink&oid=6521494

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21564-112644

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 08
-Paragraph d
-Article 4

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 29, 30, 31
-Article 5

Reference 16: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 4
-Section E

Reference 17: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 08
-Article 4

Reference 18: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 4
-Section C

Reference 19: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Article 3

+ Details

Derivative Liabilites

9 Months Ended

Sep. 30, 2014

Derivative Liabilities [Abstract]

DERIVATIVE LIABILITIES

Note 6 – Derivative liabilities

Fair value of financial instruments is defined as an exit price, which is the price that would be received upon sale of an asset or paid upon transfer of a liability in an orderly transaction between market participants at the measurement date. The degree of judgment utilized in measuring the fair value of assets and liabilities generally correlates to the level of pricing observability. Financial assets and liabilities with readily available, actively quoted prices or for which fair value can be measured from actively quoted prices in active markets generally have more pricing observability and require less judgment in measuring fair value. Conversely, financial assets and liabilities that are rarely traded or not quoted have less price observability and are generally measured at fair value using valuation models that require more judgment. These valuation techniques involve some level of management estimation and judgment, the degree of which is dependent on the price transparency of the asset, liability or market and the nature of the asset or liability. The Company has categorized its financial assets and liabilities measured at fair value into a three-level hierarchy.

The conversion feature embedded within the Company’s convertible notes payable and the warrants issued in connection with the Offering (as defined in Note 5 above) did not have fixed settlement provisions on the dates they were initially issued because the conversion and exercises prices could have been lowered if the Company would have issued securities at lower prices before conversion.

The derivative liabilities were valued using the Black-Scholes option valuation model and the following weighted average assumptions on the following dates:

	February 21, 2014			February 18, 2014			January 13, 2014
Embedded Conversion Feature and Warrant Liability:
Risk-free interest rate		1.52	%		.10	%		1.60	%
Expected volatility		105.36	%		105.36	%		123.54	%
Expected life (in years)		4.88			.75			5.00
Expected dividend yield		-			-			-
Number of shares		1,391,539			55,497			941,539
Fair value	$	4,514,772		$	98,722		$	3,431,541

The risk-free interest rate was based on rates established by the Federal Reserve. Since the Company’s common stock has not been publicly traded for a sufficiently long period of time, the Company is utilizing an expected volatility figure based on a review of the historical volatilities, over a period of time, equivalent to the expected life of the instrument being valued, of similarly positioned public companies within its industry. The expected life of the conversion feature was determined by the maturity date of the Note (as defined in Note 4) and the expected life of the Warrants was determined by their expiration dates. The expected dividend yield was based upon the fact that the Company has not historically paid dividends on its common stock and does not expect to pay dividends on its common stock in the future.

Fair Value Measurement

Valuation Hierarchy

ASC 820, “Fair Value Measurements and Disclosures,” establishes a valuation hierarchy for disclosure of the inputs to valuation used to measure fair value. This hierarchy prioritizes the inputs into three broad levels as follows. Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2 inputs are quoted prices for similar assets and liabilities in active markets or inputs that are observable for the asset or liability, either directly or indirectly through market corroboration, for substantially the full term of the financial instrument. Level 3 inputs are unobservable inputs based on the Company’s own assumptions used to measure assets and liabilities at fair value. A financial asset or liability’s classification within the hierarchy is determined based on the lowest level input that is significant to the fair value measurement. The Company had no liabilities carried at fair value measured on a recurring basis as of September 30, 2014.

The carrying amounts of cash, inventory, prepaid expenses, accounts payable and accrued liabilities approximate their fair value due to their short maturities. The Company’s other financial instruments included its convertible notes payable obligations. The carrying value of these instruments approximated fair value, as they bear terms and conditions comparable to market for obligations with similar terms and maturities. The Company measures the fair value of financial assets and liabilities based on the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The Company maximizes the use of observable inputs and minimizes the use of unobservable inputs when measuring fair value.

Level 3 liabilities are valued using unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the derivative liabilities. For fair value measurements categorized within Level 3 of the fair value hierarchy, the Company’s accounting department, who reports to the Principal Financial Officer, determines its valuation policies and procedures. The development and determination of the unobservable inputs for Level 3 fair value measurements and fair value calculations are the responsibility of the Company’s accounting department and are approved by the Principal Financial Officer.

Level 3 Valuation Techniques

Level 3 financial liabilities consisted of the conversion feature liability and common stock purchase warrants for which there is no current market for these securities such that the determination of fair value requires significant judgment or estimation. Changes in fair value measurements categorized within Level 3 of the fair value hierarchy are analyzed each period based on changes in estimates or assumptions and recorded as appropriate. A significant decrease in the volatility or a significant decrease in the Company’s stock price, in isolation, would result in a significantly lower fair value measurement. As of September 30, 2014, there were no transfers in or out of Level 3 from other levels in the fair value hierarchy.

	For the			For the		For the
	Nine Months			Nine Months		Three Months
	Ended			Ended		Ended
	September 30,			September 30,		September 30,
	2014			2013		2013
Beginning liability balance	$	1,650,243		$	-	$	43,324
Recognition of derivative value in equity		3,356,579			-		-
Recognition of conversion feature liability		-			44,966	-
Net unrealized gain on derivative liabilities in equity		(373,110	)		-		-
Net unrealized (gain) loss on conversion feature liabilities		(20,218	)		37,560		39,202
Adjustment to additional paid-in capital upon conversion and modification		(4,613,494	)		-		-
	$	-		$	82,526	$	82,526

The Company held no Level 3 financial instruments at September 30, 2014 or in the three months then ended.

Commitments and Contingencies

9 Months Ended

Sep. 30, 2014

Commitments and Contingencies [Abstract]

COMMITMENTS AND CONTINGENCIES

Note 7 - Commitments and Contingencies

Legal Matters

From time to time, the Company is subject to legal proceedings arising in the ordinary course of business. Such matters are subject to uncertainties and outcomes are not predictable with assurance. Management believes at this time that there are no ongoing matters that will have a material adverse effect on the Company's business, financial position, results of operations, or cash flows.

Commitments

In October 2012, the Company entered into an agreement with a consultant to provide public relations and marketing services to the Company. Pursuant to the agreement, the Company agreed to pay the consultant a monthly cash retainer of $5,000 and to issue the consultant shares of common stock per month with a fair value of $10,000 as compensation for services provided. In addition to the monthly retainer, the consultant is to be reimbursed for other expenses incurred in connection with certain marketing events The Company entered into a new agreement with this consultant on November 1, 2013 for a period of six (6) months and agreed to pay the consultant a monthly cash retainer of $5,000. On July 1, 2014, the Company entered into a new twelve (12) month agreement with the consultant. The Company agreed to pay the consultant a monthly cash retainer of $5,000 and to issue the consultant shares of common stock per month with a fair value of $10,000 as compensation for services provided. During the nine and three months ended September 30, 2014, the Company paid the consultant $247,502 and $84,735, respectively pursuant to this agreement. Also during the nine and three months ended September 30, 2014, 10,410 and 7,965 shares of common stock, respectively, were paid to the consultant as compensation for services provided with a fair value of $40,000 and $30,000, respectively. During the nine and three months ended September 30, 2013, 165,744 and 45,744 shares of common stock, were paid to the consultant as compensation for services provided with a fair value of $90,000 and $60,000, respectively.

On September 12, 2014, the Company entered into a lease agreement for office space in Oxford, Connecticut. The term of the lease is for two (2) years with a monthly rent of $2,300 in the first year, increasing to $2,450 per month in the second year. On October 3, 2014, the Company entered into a lease agreement for warehouse space in Melbourne, Florida. The lease term commences on January 1, 2015. The term of the lease is for three (3) years with a monthly rent amount of $6,365 which includes the base rent, an escrow for taxes and insurance, common area maintenance charges and applicable sale tax. The Company incurred rent expense of $13,842 and $3,819 for the nine and three months ended September 30, 2014, respectively. Minimum lease payments for non-cancelable operating leases are as follows:

Future Lease Obligations

2014 (remaining)	$	11,866
2015		124,698
2016		121,106
2017		87,043
Total future lease obligations	$	344,713

On November 7, 2013, the Company entered into a three-year distribution and supply agreement with Voice of Big Data Solutions, Pvt. Ltd. (“VOBD”) for the distribution of the Company’s 3D facial recognition products in India and Sri Lanka on an exclusive basis and the Middle East and Singapore on a non-exclusive basis. The agreement is subject to termination at any time after the initial three-year term by either the Company or VOBD upon sixty (60) days written notice.

On July 3, 2014, the Company entered into a purchase commitment with a certain vendor for an aggregate amount of $696,500. The purchase commitment calls for monthly deliveries through February 1, 2015. As of September 30, 2014, the Company has paid $41,790 towards this purchase commitment.

On September 24, 2014, the Company entered into a private label distribution agreement with a company specializing in facial recognition technology and the agreement is for five (5) years and is renewable by mutual consent. The Company has agreed to pay a royalty of twenty percent (20%) on the net sales incorporating this technology subject to a monthly minimum royalty of $5,000.

On October 13, 2014, the Company entered into an agreement with a sales and marketing group to provide consulting services including the development and execution of a strategic market plan for the Wocket™. The term of the agreement is for fifteen months and the fee for services is $250,000. The agreement calls for the total payment to be made in three installments. The Company paid $125,000 upon execution of the agreement.

Effective October 1, 2012, Nxt-ID entered into an employment agreement with its Chief Executive Officer. The employment agreement provides for:

An initial term of three (3) years beginning on October 1, 2012.

An initial base salary of $150,000 per year. In January 2014, upon the successful completion of the MobileWocket prototype, the salary was increased to $300,000 in accordance with the agreement.

Payment of all necessary and reasonable out-of-pocket expenses incurred by the executive in the performance of his duties under the agreement.

Eligibility to participate in bonus or incentive compensation plans that may be established by the board of directors from time to time applicable to the executive's services.

Eligibility to receive equity awards as determined by the board of directors, or a committee of the board of directors, composed in compliance with the corporate governance standards of any applicable listing exchange.

Summary of Significant Accounting Policies (Policies)	9 Months Ended
Summary of Significant Accounting Policies (Policies)	Sep. 30, 2014
Summary of Significant Accounting Policies [Abstract]
USE OF ESTIMATES IN THE FINANCIAL STATEMENTS	*Use of Estimates in the Financial Statements* The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
PRINCIPLES OF CONSOLIDATION	*Principles of Consolidation* The consolidated financial statements include the accounts of Nxt-ID and its wholly-owned subsidiary, 3D-ID. Intercompany balances and transactions have been eliminated upon consolidation.
RESTRICTED CASH	*Restricted Cash* Restricted cash is comprised of amounts held by credit card processors until the Company establishes a history of activity and the processor is able to estimate potential charge back risk. The balances are rolling and held by the processor for a period of less than a year and therefore reported as a current asset on the accompanying condensed consolidated balance sheets.
INVENTORY	*Inventory* Inventory consists principally of raw materials and is valued at the lower of cost or market with cost determined using the first-in, first-out method and with market defined as the lower of replacement cost or realizable value. As of September 30, 2014 inventory is comprised of $32,619 in raw materials on hand. In addition, as an early stage entity, the Company is required to prepay for raw materials with certain vendors until credit terms can be established. As of September 30, 2014, $165,153 of prepayments made for inventory is included in prepaid expenses on the condensed consolidated balance sheet.
REVENUE RECOGNITION	*Revenue Recognition* The Company’s 3D facial recognition and identification products are currently available for sale and the Company has begun accepting pre-orders on its Mobile Bio Wocket. The Company recognizes revenue in connection with the sale of these products when persuasive evidence of an arrangement exists, the service has been rendered or product delivery has occurred, the price is fixed or readily determinable and collectability of the sale is reasonably assured. As of September 30, 2014, the Company has received $117,088 in customer deposits in connection with pre-orders of its Mobile Bio Wocket.
CONVERTIBLE INSTRUMENTS	*Convertible Instruments* The Company applies the accounting standards for derivatives and hedging and for distinguishing liabilities from equity when accounting for hybrid contracts that feature conversion options. The accounting standards require companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments according to certain criteria. The criteria include circumstances in which (i) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (ii) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (iii) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. The derivative is subsequently marked to market at each reporting date based on current fair value, with the changes in fair value reported in the results of operations. Conversion options that contain variable settlement features, such as provisions to adjust the conversion price upon subsequent issuances of equity or equity linked securities at exercise prices more favorable than that featured in the hybrid contract, generally result in their bifurcation from the host instrument. The Company accounts for convertible debt instruments when the Company has determined that the embedded conversion options should not be bifurcated from their host instruments in accordance with ASC 470-20 “Debt with Conversion and Other Options.” The Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt. See Note 5 below.
DEBT DISCOUNT AND AMORTIZATION OF DEBT DISCOUNT	*Debt Discount and amortization of debt discount* Debt discount represents the fair value of embedded conversion options of various convertible debt instruments and attached convertible equity instruments issued in connection with debt instruments. The debt discount is amortized over the earlier of (i) the term of the debt or (ii) conversion of the debt. The amortization of debt discount is included as a component of interest and other expenses, net in the accompanying statements of operations.
INCOME TAXES	*Income Taxes* The Company uses the asset and liability method of accounting for income taxes in accordance with ASC Topic 740, "Income Taxes." Under this method, income tax expense is recognized for the amount of: (i) taxes payable or refundable for the current year and (ii) deferred tax consequences of temporary differences resulting from matters that have been recognized in an entity's financial statements or tax returns. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the year in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the results of operations in the period that includes the enactment date. A valuation allowance is provided to reduce the deferred tax assets reported if, based on the weight of the available positive and negative evidence, it is more likely than not that some portion or all of the deferred tax assets will not be realized. ASC Topic 740-10-30 clarifies the accounting for uncertainty in income taxes recognized in an enterprise's financial statements and prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. ASC Topic 740-10-40 provides guidance on de-recognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition. The Company will classify as income tax expense any interest and penalties. The Company has no material uncertain tax positions for any of the reporting periods presented. Generally, the tax authorities may examine the partnership/corporate tax returns for three years from the date of filing. The Company has filed all of its tax returns for the year ended December 31, 2013. As a result, the Company’s net operating loss carryovers will now be available to offset any future taxable income.
STOCK-BASED COMPENSATION	*Stock-Based Compensation* The Company accounts for equity instruments issued to non-employees at their fair value on the measurement date. The measurement of stock-based compensation is subject to periodic adjustment as the underlying equity instrument vests or becomes non-forfeitable. Non-employee stock-based compensation charges are amortized over the vesting period or as earned.
NET LOSS PER SHARE	*Net Loss per Share* Basic loss per share was computed using the weighted average number of common shares outstanding. Diluted loss per share includes the effect of diluted common stock equivalents. Potentially dilutive securities realizable from the exercise of 3,629,776 warrants as of September 30, 2014 were excluded from the computation of diluted net loss per share because the effect of their inclusion would have been anti-dilutive. As of September 30, 2013, potentially dilutive securities realizable from the conversion of the Company’s then outstanding note payable into 120,000 shares of common stock and the exercise of warrants for the purchase of 204,600 common shares were excluded from the computation of diluted net loss per share because the effect of their inclusion would have been anti-dilutive.
RESEARCH AND DEVELOPMENT	*Research and Development* Research and development costs consist of expenditures incurred during the course of planned research and investigation aimed at the discovery of new knowledge that would be useful in developing new products or processes. The Company expenses all research and development costs as incurred.

Recent Events (Details) - USD ($)	1 Months Ended		3 Months Ended		9 Months Ended
Recent Events (Details) - USD ($)	Sep. 15, 2014	Jan. 31, 2014	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2013
Recent Events [Abstract]
Net Loss			$ (2,707,749)	$ (474,000)	$ (4,956,099)	$ (1,075,749)
Non-cash charges					2,403,481
Working capital			4,595,829		4,595,829
Stockholders Equity			$ 4,632,727		4,632,727		$ (1,831,393)
Proceeds from issuance of common stock and exercise of warrants					$ 7,225,056
Issue additional shares of common stock	2,127,273
Warrants issued to purchase common stock	2,127,273	41,539
Common stock shares issued, per share	$ 2.75
Warrant issued, per share	$ 2.75
Weighted Average Remaining Life In Years Outstanding	5 years
Class of warrant begining date	Sep. 15, 2014
Warrants exercise price	$ 3.288
Net proceeds from initial public offering	$ 4,954,042

Convertible Notes Payable (Details) - USD ($)		1 Months Ended	9 Months Ended
Convertible Notes Payable (Details) - USD ($)	Feb. 11, 2014	Dec. 21, 2012	Sep. 30, 2014	Sep. 30, 2013	Jan. 31, 2013
Convertible Notes Payable [Abstract]
Convertible notes payable		$ 75,000			$ 75,000
Convertible notes payable, Maturity date	Dec. 21, 2014
Unamortized debt discount expensed			$ 26,755	$ 11,109
Outstanding convertible note converted amount	$ 150,000	$ 150,000
Conversion of accrued interest into common stock	$ 21,485
Percentage of discount on closing price	25.00%
Shares issued for debt relief	55,497
Shares issued for debt relief, amount	$ 171,485
Unrealized gain on change in fair value of conversion feature			20,218
Conversion feature in additional paid-in capital			$ 98,722
Debt conversion description	CII regarding converting its outstanding convertible note of $150,000, along with accrued interest of $21,485, into common stock at a 25% discount to the Company's closing stock price on February 17, 2014.

Stockholders' Equity (Details) - USD ($)	1 Months Ended	9 Months Ended
Stockholders' Equity (Details) - USD ($)	Sep. 15, 2014	Sep. 30, 2014
Weighted Average Exercise Price
Weighted Average Exercise Price Outstanding, ending	$ 2.75
Weighted Average Remaining Life In Years
Weighted Average Remaining Life In Years Outstanding, beginning	5 years
Warrants [Member]
Number of Warrants
Number of Warrants Outstanding, beginning		454,600
Number of Warrants Issued		3,675,176
Number of Warrants Exercised		(500,000)
Number of Warrants Cancelled
Number of Warrants Outstanding, ending		3,629,776
Number of Warrants Exercisable		3,629,776
Weighted Average Exercise Price
Weighted Average Exercise Price Outstanding, beginning		$ 3.23
Weighted Average Exercise Price Issued		2.79
Weighted Average Exercise Price Exercised		3.00
Weighted Average Exercise Price Cancelled
Weighted Average Exercise Price Outstanding, ending		2.80
Weighted Average Exercise Price Exercisable		$ 2.80
Weighted Average Remaining Life In Years
Weighted Average Remaining Life In Years Outstanding, beginning		4 years 11 months 19 days
Weighted Average Remaining Life In Years Issued		4 years 9 months 4 days
Weighted Average Remaining Life In Years Outstanding, ending		4 years 9 months 4 days
Weighted Average Remaining Life In Years Exercisable		4 years 9 months 4 days
Intrinsic Value
Intrinsic Value Outstanding, beginning		$ 351,300
Intrinsic Value Outstanding, ending		786,438
Intrinsic Value Exercisable		$ 786,438

Stockholders' Equity (Details Textual)		1 Months Ended			3 Months Ended	9 Months Ended		12 Months Ended
Stockholders' Equity (Details Textual)	Jan. 13, 2014 USD ($) $ / shares shares	Sep. 15, 2014 USD ($) $ / shares shares	Feb. 21, 2014 USD ($) $ / shares shares	Jan. 31, 2014 USD ($) $ / shares shares	Sep. 30, 2014 USD ($) directors $ / shares shares	Sep. 30, 2014 USD ($) directors $ / shares shares	Sep. 30, 2013 USD ($)	Dec. 31, 2013 USD ($) $ / shares shares
Exercised oversubscription amount in offering		$ 3.288
Common stock issued \| shares		2,127,273			24,670,995	24,670,995		21,937,822
Common stock, par value \| $ / shares	$ 2.75	$ 2.75			$ 0.0001	$ 0.0001		$ 0.0001
Stock sold in private offering, warrant shares \| shares		2,127,273
Common stock exercise price \| $ / shares		$ 2.75
Proceeds from public offering		$ 4,954,042
Offering costs				$ 100,006				$ 56,820
Warrant received by private placement agent \| shares	2.75			41,539
Warrants issued to purchase common stock \| shares		2,127,273		41,539
Unrealized gain on derivative liabilities						$ 448,072
Derivative liability - warrants						3,431,541
Proceeds from warrants exercised	$ 4,000					1,020
Warrant term							5 years
Inducement costs					$ 210,940	$ 1,262,038
Restricted shares issued \| shares	261,131				5,859	12,206
Restricted shares issued, fair value					$ 15,000	$ 40,000
Number of non executive directors under plan \| directors					3	3
Shares issued to consultants for services \| shares						54,229
Shares issued to consultants for services, fair value						$ 195,000
Long-term stock incentive plan description						The maximum aggregate number of shares of common stock that may be issued under the LTIP, including stock awards and stock appreciation rights, is limited to 10% of the shares of common stock outstanding on the first business or trading day of any fiscal year, which is 2,193,782 at January 1, 2014.
Additional Paid in Capital					$ 11,339,769	$ 11,339,769		$ (80,177)
January 13, 2014 offering [Member]
Closing balance of private offering						1,000,000
Exercised oversubscription amount in offering						350,000
Proceeds from issuance of stock, value						$ 1,350,000
Common stock issued \| shares					415,387	415,387
Common stock, par value \| $ / shares					$ 0.0001	$ 0.0001
Stock sold in private offering, warrant shares \| shares						138,463
Common stock exercise price \| $ / shares						$ 3.25
Proceeds from private offering						$ 450,000
Securities Purchase Agreement [Member]
Stock sold in private offering, warrant shares \| shares						1,350,000
Maximum [Member]
Common stock exercise price \| $ / shares	$ 3.00
Minimum [Member]
Common stock exercise price \| $ / shares	$ 2.00
Common Stock [Member]
Proceeds from issuance of stock, value						$ 1,500,000
Common stock issued \| shares					500,000	500,000
Common stock exercise price \| $ / shares						$ 3.00
Common stock unit under public offering \| shares				276,924				138,463
Common unit par value \| $ / shares				$ 3.25
Proceeds from public offering								$ 450,000
Offering costs						$ 30,000
Retirement of stock by founders, shares \| shares				276,924		400,000		138,463
Stock issued under LTIP - shares \| shares						2,193,782
Warrants [Member]
Proceeds from public offering								$ 900,000
Number of Warrants Exercised \| shares			1,396,139			500,000
Additional Paid in Capital			$ 4,514,772
Warrants [Member] \| Maximum [Member]
Common stock exercise price \| $ / shares			$ 3.25
Warrants [Member] \| Minimum [Member]
Common stock exercise price \| $ / shares			$ 3.00

Derivative Liabilities (Details) - USD ($)	9 Months Ended
Derivative Liabilities (Details) - USD ($)	Sep. 30, 2014	Dec. 31, 2013	Sep. 30, 2013	Jul. 01, 2013	Dec. 31, 2012
Embedded Conversion Feature:
Fair value		$ 1,650,243	$ 82,526	$ 43,324
February 21, 2014
Embedded Conversion Feature:
Risk-free interest rate	1.52%
Expected volatility	105.36%
Fair Value Assumptions, Expected Term	4 years 10 months 17 days
Expected dividend yield
Number of shares	1,391,539
Fair value	$ 4,592,635
February 18, 2014
Embedded Conversion Feature:
Risk-free interest rate	0.10%
Expected volatility	105.36%
Fair Value Assumptions, Expected Term	9 months
Expected dividend yield
Number of shares	55,497
Fair value	$ 98,722
January 14, 2014
Embedded Conversion Feature:
Risk-free interest rate	1.60%
Expected volatility	123.54%
Fair Value Assumptions, Expected Term	5 years
Expected dividend yield
Number of shares	941,539
Fair value	$ 3,431,541

Commitments and Contingencies (Details Textual) - USD ($)									1 Months Ended			3 Months Ended		9 Months Ended
	Oct. 13, 2014	Sep. 12, 2014	Jul. 02, 2014	Nov. 07, 2013	Oct. 31, 2013	Jul. 01, 2013	Jun. 01, 2013	Oct. 01, 2012	Sep. 24, 2014	Oct. 16, 2013	Oct. 31, 2012	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Commitments And Contingencies [Line Items]
Shares issued to consultants for services, fair value														$ 195,000
Shares issued to consultants for services														54,229
Consultant Agreement [Member]
Commitments And Contingencies [Line Items]
Shares issued to consultants for services, fair value							$ 10,000				$ 10,000	$ 30,000	$ 30,000	$ 40,000	$ 90,000
Shares issued to consultants for services												7,965	15,744	10,410	165,744
Consultant fees paid in cash							$ 5,000				$ 5,000	$ 84,735		$ 247,502
Extended contract period							1 year
Consultant Agreement One [Member]
Commitments And Contingencies [Line Items]
Consultant fees paid in cash					$ 5,000
Term of agreement					6 months
Consultant Agreement Two [Member]
Commitments And Contingencies [Line Items]
Shares issued to consultants for services, fair value						$ 10,000
Consultant fees paid in cash						$ 5,000
Term of agreement						12 months
Lease Agreement [Member]
Commitments And Contingencies [Line Items]
Term of the lease										3 years
Rent expenses										$ 1,250		$ 3,819		$ 13,842
Increase rate in rental expense										3.00%
Lease Agreement One [Member]
Commitments And Contingencies [Line Items]
Term of the lease		2 years
Lease and rental expense current year		$ 2,300
Lease and rental expense next year		$ 2,450
Distribution And Supply Agreement [Member]
Commitments And Contingencies [Line Items]
Term of agreement				3 years
Termination of agreement description				The agreement is subject to termination at any time after the initial three-year term by either the Company or VOBD upon sixty (60) days written notice.
Purchase Commitment [Member]
Commitments And Contingencies [Line Items]
Aggregate amount of purchase commitment			$ 696,500
Payment for purchase commitment			$ 130,000
Purchase commitment, description			The purchase commitment calls for monthly deliveries through February 1, 2015
Distribution agreement [Member]
Commitments And Contingencies [Line Items]
Term of agreement									5 years
Royalty percentage									20.00%
Monthly minimum royalty									$ 5,000
Consultant Agreement Three [Member]
Commitments And Contingencies [Line Items]
Consultant fees paid in cash	$ 250,000
Prepaid fee for services	$ 125,000
Term of agreement	15 months
Employment Agreement [Member] \| Chief Executive Officer [Member]
Commitments And Contingencies [Line Items]
Term of agreement								3 years
Initial base salary								$ 150,000
Increased in salaries								$ 300,000

Organization and Basis of Presentation	9 Months Ended
Organization and Basis of Presentation	Sep. 30, 2014
Organisation and Basis of Presentation [Abstract]
ORGANIZATION AND BASIS OF PRESENTATION	Note 1 – Organization and Basis of Presentation *Organization and Principal Business Activity* Nxt-ID, Inc. (“Nxt-ID” or the “Company”) was incorporated in the State of Delaware on February 8, 2012. Nxt-ID is a biometrics and authentication company focused on the growing m-commerce market with an innovative MobileBio™ suite of biometric solutions that secure mobile platforms. The Company also serves the access control and law enforcement facial recognition markets. 3D-ID, LLC (“3D-ID”) was organized and registered in the State of Florida on February 14, 2011. The Company is an early stage company engaged in the design, research and development, integration, analysis, modeling, system networking, sales and support of intelligent surveillance, three dimensional facial recognition and three dimensional imaging devices and systems primarily for identification and access control in the security industries. On June 25, 2012, Nxt-ID, a company having similar ownership as 3D-ID, acquired 100% of the membership interests in 3D-ID (the “Acquisition”) in exchange for 20,000,000 shares of Nxt-ID common stock. Since this was a transaction between entities under common control, in accordance with Accounting Standards Codification (“ASC”) 805, “Business Combinations”, Nxt-ID recognized the net assets of 3D-ID at their carrying amounts in the accounts of Nxt-ID on the date that 3D-ID was organized. *Basis of Presentation* The accompanying unaudited condensed consolidated financial statements as of September 30, 2014 and for the three and nine months then ended have been prepared in accordance with the accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and pursuant to the instructions to Form 10-Q and Article 8 of Regulation S-X of the Securities and Exchange Commission (“SEC”) and on the same basis as the Company prepares its annual audited consolidated financial statements. The condensed consolidated balance sheet as of September 30, 2014, the condensed consolidated statements of operations for the three and nine months ended September 30, 2014 and 2013 and the condensed consolidated statements of cash flows for the nine months ended September 30, 2014 and 2013 are unaudited, but include all adjustments, consisting only of normal recurring adjustments, which the Company considers necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The results for the three and nine months ended September 30, 2014 are not necessarily indicative of results to be expected for the year ending December 31, 2014 or for any future interim period. The condensed consolidated balance sheet at December 31, 2013 has been derived from audited consolidated financial statements. However, it does not include all of the information and notes required by GAAP for complete consolidated financial statements. The accompanying condensed consolidated financial statements should be read in conjunction with the consolidated financial statements for the year ended December 31, 2013 and notes thereto included in the Company’s annual report on Form 10-K, which was filed with the SEC on February 25, 2014.

Convertible Notes Payable	9 Months Ended
Convertible Notes Payable	Sep. 30, 2014
Convertible Notes Payable [Abstract]
CONVERTIBLE NOTES PAYABLE	Note 4 - Convertible Notes Payable On December 13, 2012, the Company received approval from Connecticut Innovations, Inc. (“CII”) for a Convertible Note (the “Note”) in the amount of $150,000. The Company received the first tranche of $75,000 on December 21, 2012 and the second tranche of $75,000 on January 31, 2013. The Note’s maturity date was December 21, 2014. The Company received notice on February 11, 2014 from CII regarding converting its outstanding convertible note of $150,000, along with accrued interest of $21,485, into common stock at a 25% discount to the Company’s closing stock price on February 17, 2014. Since February 17, 2014 was a holiday, the Company used its closing stock price on February 18, 2014 to determine the number of shares issued to CII resulting from the conversion. The Company issued 55,497 shares in full relief of its outstanding debt and accrued interest of $171,485. Since the Note was converted on February 18, 2014, the Company re-measured the conversion feature liability associated with the convertible note payable on that date. The Company recorded an unrealized gain on the change in the fair value of the conversion feature liability of $20,218 for the nine months ended September 30, 2014 (see Note 6 below) and reclassified the re-measured conversion feature of $98,722 to additional paid-in capital. Since the Note was converted, the remaining unamortized portion of the debt discount of $26,755 was expensed during the nine months ended September 30, 2014.

Organization and Basis of Presentation (Details)	1 Months Ended
Organization and Basis of Presentation (Details)	Jun. 25, 2012 shares
Organisation and Basis of Presentation [Abstract]
Business acquisition, membership interests percentage	100.00%
Common stock acquired in exchange	20,000,000

Summary of Significant Accounting Policies (Details Textual)	9 Months Ended
	Sep. 30, 2014 USD ($) shares
Potentially dilutive securities \| shares	3,629,776
Prepaid inventory \| $	$ 165,000
Raw materials on hand \| $	32,619
Customer deposits in connection with pre-orders of its MobileBio Wocket \| $	$ 117,088
Conversion of Notes Payable [Member]
Potentially dilutive securities \| shares	120,000
Warrants [Member]
Potentially dilutive securities \| shares	204,600

Subsequent Events (Details) - Subsequent Event [Member] - USD ($)	Oct. 15, 2014	Oct. 01, 2014
Subsequent Event [Line Items]
Common stock issued for grand option	5,000	11,718
Common stock issued, grand, value	$ 43,250	$ 43,250

Derivative Liabilities (Details 1) - USD ($)	3 Months Ended	9 Months Ended
Derivative Liabilities (Details 1) - USD ($)	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Beginning liability balance	$ 43,324	$ 1,650,243
Recognition of derivative value in equity		3,356,579
Recognition of conversion feature liability			44,966
Net unrealized gain on derivative liabilities in equity		(373,110)
Net unrealized (gain) loss on conversion feature liabilities	39,202	(20,218)	37,560
Adjustment to additional paid-in capital upon conversion and modification		(4,613,494)
Ending liability balance	$ 82,526		$ 82,526

Commitments and Contingencies (Details)	Sep. 30, 2014 USD ($)
Commitments and Contingencies [Abstract]
2014 (remaining)	$ 11,866
2015	124,698
2016	121,106
2017	87,043
Total future lease obligation	$ 344,713